• 

  OCRFA is now OCRA

  (October 1, 2018) We’re shortening our name, to make it easier to say and easier to write. OCRFA is now Ovarian Cancer Research Alliance (OCRA). You can find us at ocrahope…

• 

  Maintenance olaparib Improves Progression-Free Survival in Phase III Clinical Trial

  (October 23, 2018) Olaparib, or Lynparza, was shown to increase progression-free survival (PFS) by almost three years in an ongoing trial known as SOLO-1…

• 

  OCRA Research Shows How Cancer Cells Negatively Impact the Communication between the Ovary and Fallopian Tube

  (October 22, 2018) A team at the University of Illinois at Chicago, including OCRA grantee Matthew Dean, PhD, recently discovered the role that cancer cells have on their immediate environment…

• 

  Kunle Odunsi, MD, PhD, Elected to National Academy of Medicine

  (October 18, 2018) Longtime OCRA Scientific Advisory Committee member and former grantee Kunle Odunsi, MD, PhD, has been elected to the National Academy of Medicine—a distinguished lifetime…

• 

  For Some, Statin Use Can Decrease the Risk of Ovarian Cancer

  (November 13, 2018) The International Journal of Cancer recently published a study that explored the use of statins, which reduces one’s lipids, and their effect on ovarian cancer risk…

• 

  Simple Cysts Found by Ultrasound Don’t Require Action

  (November 16, 2018) JAMA Internal Medicine recently published an eleven year study of over 72,000 women that found having a simple ovarian cyst does not increase one’s risk of ovarian cancer…

All News